找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Metasurfaces: Towards Tunable and Reconfigurable Meta-devices; Weiming Zhu,Ai-Qun Liu Book 2023 The Editor(s) (if applicable) and The Auth

[復(fù)制鏈接]
樓主: monster
21#
發(fā)表于 2025-3-25 05:10:55 | 只看該作者
Weiming Zhu,Ai-Qun Liuwth such as that seen with desmoids, for cosmetic d- figurations and functional loss as seen with keloids or endocrine orbitopathy, or for life-threatening complications such as hepatic hemangiomas or juvenile angiofibromas that occur in children or adolescents. Many of the non-malignant diseases ca
22#
發(fā)表于 2025-3-25 08:51:04 | 只看該作者
Weiming Zhu,Ai-Qun Liud. Evidence for the respective accuracy and planning considerations are given for each modality. Finally, the rigorous quality assurance (QA) requirements are reviewed, specifically highlighting small-field dosimetry and mechanical accuracy as the two most important topics that must be well characte
23#
發(fā)表于 2025-3-25 12:13:36 | 只看該作者
24#
發(fā)表于 2025-3-25 18:18:20 | 只看該作者
25#
發(fā)表于 2025-3-25 21:28:10 | 只看該作者
Weiming Zhu,Ai-Qun Liual imaging technique which allows for characterizing pharmacokinetic features reflecting the prostatic vascularization through a series of high temporal resolution T1-weighted images following the administration of contrast medium. In-vivo proton MRS investigates the biochemical constituents of pros
26#
發(fā)表于 2025-3-26 02:46:10 | 只看該作者
27#
發(fā)表于 2025-3-26 04:36:24 | 只看該作者
Weiming Zhu,Ai-Qun Liuhe RT modality chosen. In this chapter, we have described in detail about patient selection, tumor factors, choosing the right treatment technique, and planning considerations for each of these treatment modalities for patients with primary non-melanomatous skin cancers (NMSCs) treated with primary
28#
發(fā)表于 2025-3-26 11:36:26 | 只看該作者
Weiming Zhu,Ai-Qun Liuhe RT modality chosen. In this chapter, we have described in detail about patient selection, tumor factors, choosing the right treatment technique, and planning considerations for each of these treatment modalities for patients with primary non-melanomatous skin cancers (NMSCs) treated with primary
29#
發(fā)表于 2025-3-26 12:54:20 | 只看該作者
Weiming Zhu,Ai-Qun Liuhe RT modality chosen. In this chapter, we have described in detail about patient selection, tumor factors, choosing the right treatment technique, and planning considerations for each of these treatment modalities for patients with primary non-melanomatous skin cancers (NMSCs) treated with primary
30#
發(fā)表于 2025-3-26 18:24:13 | 只看該作者
Weiming Zhu,Ai-Qun Liuhe RT modality chosen. In this chapter, we have described in detail about patient selection, tumor factors, choosing the right treatment technique, and planning considerations for each of these treatment modalities for patients with primary non-melanomatous skin cancers (NMSCs) treated with primary
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 14:55
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
巴中市| 鹤山市| 嘉黎县| 偃师市| 高淳县| 略阳县| 门源| 霞浦县| 鸡泽县| 诸暨市| 繁昌县| 金乡县| 澄迈县| 涞源县| 大新县| 沾益县| 青海省| 岚皋县| 江川县| 瑞昌市| 介休市| 和林格尔县| 延寿县| 石城县| 淮安市| 镇赉县| 广灵县| 交口县| 山丹县| 亚东县| 宁化县| 甘洛县| 乳山市| 革吉县| 冀州市| 进贤县| 衡山县| 汝城县| 神木县| 南川市| 平利县|